BC
TMO icon

Brinker Capital’s Thermo Fisher Scientific TMO Stock Holding History

Brinker Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$7.89M Sell
21,761
-1,718
-7% -$576K 0.25% 91
2020
Q1 		$6.66M Sell
23,479
-2,452
-9% -$773K 0.27% 79
2019
Q4 		$8.43M Sell
25,931
-2,087
-7% -$633K 0.26% 82
2019
Q3 		$8.16M Buy
28,018
+135
+0.5% +$38.7K 0.28% 75
2019
Q2 		$8.19M Sell
27,883
-1,204
-4% -$332K 0.3% 71
2019
Q1 		$7.96M Sell
29,087
-470
-2% -$117K 0.3% 66
2018
Q4 		$6.62M Sell
29,557
-1,721
-6% -$404K 0.29% 70
2018
Q3 		$7.63M Sell
31,278
-7,458
-19% -$1.72M 0.28% 72
2018
Q2 		$8.03M Sell
38,736
-1,597
-4% -$339K 0.31% 56
2018
Q1 		$8.33M Sell
40,333
-1,472
-4% -$309K 0.33% 54
2017
Q4 		$7.94M Sell
41,805
-2,131
-5% -$408K 0.31% 59
2017
Q3 		$8.31M Sell
43,936
-1,254
-3% -$227K 0.34% 52
2017
Q2 		$7.88M Buy
45,190
+5,801
+15% +$974K 0.36% 48
2017
Q1 		$6.05M Buy
39,389
+912
+2% +$139K 0.28% 67
2016
Q4 		$5.43M Buy
+38,477
New +$5.67M 0.3% 71

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brinker Capital's TMO Position: Q2 2020 in Review

Brinker Capital reduced its Thermo Fisher Scientific (TMO) stake by 7.3% in Q2 2020, selling an estimated $576K and leaving 21,761 shares worth $7.89M. The position accounts for 0.25% of the portfolio, ranked #91.

Brinker Capital first reported a position in TMO in Q4 2016 and has held it in 15 quarters since. The position peaked at $8.43M in Q4 2019. 1,750 funds tracked by Wall St. Rank hold TMO as of Q2 2020.

  • Brinker Capital held 21,761 shares of Thermo Fisher Scientific worth $7.89M as of Q2 2020.
  • Brinker Capital sold 1,718 Thermo Fisher Scientific shares in Q2 2020, an estimated $576K.
  • Thermo Fisher Scientific made up 0.25% of Brinker Capital's portfolio in Q2 2020, its #91 holding.
  • Brinker Capital first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 15 quarters since.
  • Brinker Capital's Thermo Fisher Scientific position peaked at $8.43M in Q4 2019.
  • 1,750 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.